miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
23 Feb 2024
23 Feb 2024
Historique:
received:
27
06
2023
accepted:
05
02
2024
revised:
02
02
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
24
2
2024
Statut:
aheadofprint
Résumé
Dual-specificity phosphatase 8 (DUSP8) plays an important role as a selective c-Jun N-terminal kinase (JNK) phosphatase in mitogen-activated protein kinase (MAPK) signaling. In this study, we found that DUSP8 is silenced by miR-147b in patients with lung adenocarcinoma (LUAD), which correlates with poor overall survival. Overexpression of DUSP8 resulted in a tumor-suppressive phenotype in vitro and in vivo experimental models, whereas silencing DUSP8 with a siRNA approach abrogated the tumor-suppressive properties. We found that miR-147b is a posttranscriptional regulator of DUSP8 that is highly expressed in patients with LUAD and is associated with lower survival. NanoString analysis revealed that the MAPK signaling pathway is mainly affected by overexpression of miR-147b, leading to increased proliferation and migration and decreased apoptosis in vitro. Moreover, induction of miR-147b promotes tumor progression in vitro and in vivo experimental models. Knockdown of miR-147b restored DUSP8, decreased tumor progression in vitro, and increased apoptosis via JNK phosphorylation. These results suggest that miR-147b plays a key role in regulating MAPK signaling in LUAD. The link between DUSP8 and miR-147b may provide novel approaches for the treatment of lung cancer.
Identifiants
pubmed: 38396293
doi: 10.1038/s41388-024-02969-7
pii: 10.1038/s41388-024-02969-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SA 1923/7-1, SFB1213 (Project A01, A05, A10N)
Informations de copyright
© 2024. The Author(s).
Références
Pradhan R, Singhvi G, Kumar Dubey S, Gupta G, Dua K. MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma. Fut Med Chem. 2019. https://doi.org/10.4155/fmc-2018-0468 .
Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers. 2019;11:1618.
doi: 10.3390/cancers11101618
pubmed: 31652660
pmcid: 6827047
Johnson GL, Lapadat R. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases. Science. 2002. http://stke.sciencemag.org/cgi/cm/stkecm .
Bubici C, Papa SJNK. signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol. 2014;171:24.
doi: 10.1111/bph.12432
pubmed: 24117156
Gao PP, Qi XW, Sun N, Sun YY, Zhang Y, Tan XN, et al. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188562.
doi: 10.1016/j.bbcan.2021.188562
pubmed: 33964330
Chen HF, Chuang HC, Tan TH. Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability. Int J Mol Sci. 2019;20:2668.
doi: 10.3390/ijms20112668
pubmed: 31151270
pmcid: 6600639
Ha J, Kang E, Seo J, Cho S. Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway. Int J Mol Sci. 2019;20:6157.
doi: 10.3390/ijms20246157
pubmed: 31817617
pmcid: 6941053
Patterson KI, Brummer T, Brien PMO, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J. 2010;489:475–89.
Oehrl W, Cotsiki M, Panayotou G. Differential regulation of M3/6 (DUSP8) signaling complexes in response to arsenite-induced oxidative stress. Cell Signal. 2013;25:429–38.
doi: 10.1016/j.cellsig.2012.11.010
pubmed: 23159405
Cotsiki M, Oehrl W, Samiotaki M, Theodosiou A, Panayotou G. Phosphorylation of the m3/6 dual-specificity phosphatase enhances the activation of jnk by arsenite. Cell Signal. 2012;24:664–76.
doi: 10.1016/j.cellsig.2011.10.015
pubmed: 22100391
Ding T, Cui P, Zhou Y, Chen C, Zhao J, Wang H, et al. Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway. Mol Ther Nucleic Acids. 2018;13:244–55.
doi: 10.1016/j.omtn.2018.09.004
pubmed: 30317164
pmcid: 6187053
Singh MK, Altameemi S, Lares M, Newton MA, Setaluri V. Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance. Sci Rep. 2022;12. https://doi.org/10.1038/S41598-022-18578-X .
Zhang H, Wang M, Chen D, Luo C. Dual-specificity phosphatase 8 (DUSP8) induces drug resistance in breast cancer by regulating MAPK pathways. J Investig Med. 2022;70:1293–300.
doi: 10.1136/jim-2021-002282
pubmed: 35428675
Vasaikar S V, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46. https://doi.org/10.1093/nar/gkx1090 .
Liu J, Lin A. Role of JNK activation in apoptosis: A double-edged sword. Cell Res. 2005. http://www.cell-research.comwww.cell-research.com .
Takeuchi K, Shin-Ya T, Nishio K, Ito F. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. FEBS J. 2009. https://doi.org/10.1111/j.1742-4658.2008.06861.x .
Iorio MV, Croce CM. Causes and Consequences of microRNA Dysregulation. Cancer J. 2012;18:215.
doi: 10.1097/PPO.0b013e318250c001
pubmed: 22647357
pmcid: 3528102
Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, et al. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes. Cell. 2006;126:1203–17.
doi: 10.1016/j.cell.2006.07.031
pubmed: 16990141
Subbannayya Y, Pinto SM, Bösl K, Keshava Prasad TS, Kandasamy RK. Dynamics of Dual Specificity Phosphatases and Their Interplay with Protein Kinases in Immune Signaling. Int J Mol Sci. 2019;20. https://doi.org/10.3390/IJMS20092086 .
He Y, Su Y, Zeng # Junsong, Chong W, Hu X, Zhang Y, et al. Cancer-specific survival after diagnosis in men versus women: A pan-cancer analysis. MedComm. 2022. https://doi.org/10.1002/mco2.145 .
Ding T, Zhou Y, Long R, Chen C, Zhao J, Cui P, et al. DUSP8 phosphatase: Structure, functions, expression regulation and the role in human diseases. Cell Biosci. 2019;9. https://doi.org/10.1186/s13578-019-0329-4 .
Shillingford SR, Bennett AM. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable? Annu Rev Pharmacol Toxicol. 2023;63:617–36.
doi: 10.1146/annurev-pharmtox-051921-121923
pubmed: 36662585
pmcid: 10127142
Tournier C. The 2 Faces of JNK Signaling in Cancer. Genes Cancer. 2013;4:397.
doi: 10.1177/1947601913486349
pubmed: 24349637
pmcid: 3863340
Ha J, Kang E, Seo J, Cho S. Molecular Sciences Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway. Int J Mol Sci. 2019;20:6157.
doi: 10.3390/ijms20246157
pubmed: 31817617
pmcid: 6941053
Boulding T, Wu F, McCuaig R, Dunn J, Sutton CR, Hardy K, et al. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. PLoS One. 2016;11. https://doi.org/10.1371/JOURNAL.PONE.0148065 .
Zuchegna C, Di Zazzo E, Moncharmont B, Messina S. Dual-specificity phosphatase (DUSP6) in human glioblastoma: Epithelial-to-mesenchymal transition (EMT) involvement. BMC Res Notes. 2020;13:1–8.
doi: 10.1186/s13104-020-05214-y
Ventura JJ, Hübner A, Zhang C, Flavell RA, Shokat KM, Davis RJ. Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell. 2006;21:701–10.
doi: 10.1016/j.molcel.2006.01.018
pubmed: 16507367
Feng YY, Liu CH, Xue Y, Chen YY, Wang YL, Wu XZ. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Gene. 2020;730:144316.
doi: 10.1016/j.gene.2019.144316
pubmed: 31884109
Zhang WC, Wells JM, Chow KH, Huang H, Yuan M, Saxena T, et al. miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma. Nat Metab. 2019;1:460–74.
doi: 10.1038/s42255-019-0052-9
pubmed: 31535082
pmcid: 6750230
Dhanasekaran DN, Reddy EP. JNK Signaling in Apoptosis. Oncogene. 2008;27:6245.
doi: 10.1038/onc.2008.301
pubmed: 18931691
pmcid: 3063296
Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: Critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell. 2012;104:3–12.
doi: 10.1111/boc.201100115
pubmed: 22188537
Xu C, Liu J, Yao X, Bai Y, Zhao Q, Zhao R, et al. Downregulation of microR-147b represses the proliferation and invasion of thyroid carcinoma cells by inhibiting Wnt/β-catenin signaling via targeting SOX15. Mol Cell Endocrinol. 2020:501. https://doi.org/10.1016/J.MCE.2019.110662 .
Pullamsetti SS, Kojonazarov B, Storn S, Gall H, Salazar Y, Wolf J, et al. Lung cancer-Associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-Talk. Sci Transl Med. 2017:9. https://doi.org/10.1126/scitranslmed.aai9048 .
Salazar Y, Zheng X, Brunn D, Raifer H, Picard FSR, Zhang Y, et al. Microenvironmental Th9– and Th17– lymphocytes induce metastatic spreading in lung cancer. J Clin Invest. 2020:130. https://doi.org/10.1172/jci124037 .
Krupnick AS, Tidwell VK, Engelbach JA, Alli VV, Nehorai A, You M, et al. Quantitative monitoring of mouse lung tumors by magnetic resonance imaging. Nat Protoc. 2012;7:128–42.
doi: 10.1038/nprot.2011.424
pubmed: 22222788
Gyorffy B, Surowiak P, Budczies J, Lánczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013:8. https://doi.org/10.1371/journal.pone.0082241 .